Poland· PL-100108705

Rostil

A calcium dobesilate product containing calcii dobesilas monohydricus, registered in Poland by Aflofarm Farmacja Polska Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.

ATC C05BX01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedRostilATCC05BX01REGISTER NO.PL-100108705PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Calcium dobesilate is registered in 3 of 19 countries.

Countries holding a registration under ATC C05BX01 (calcium dobesilate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Calcium dobesilate · ATC C05BX01

3 / 19 countries

  • Czechiaprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Calcii dobesilas monohydricus
Manufacturer
Aflofarm Farmacja Polska Sp. z o.o.
Country
Poland (PL)
ATC code
C05BX01
ATC class
Calcium dobesilate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909990944040
  • gtin
    05909990944026
  • gtin
    05909990944019
  • gtin
    05909990944033

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Calcium dobesilate in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All calcium dobesilate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/39539a64-a69b-4f59-8e62-4a4aa9e6b1de
GET /v1/drugs/39539a64-a69b-4f59-8e62-4a4aa9e6b1de?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "250 mg",
  "packaging": "05909990944033 ¦ OTC ¦ 19403\n60 tabl.\n05909990944040 ¦ Rp ¦ Skasowane ¦ 19404\n60 tabl. w pojemniku\n05909990944026 ¦ Rp ¦ Skasowane ¦ 19462\n30 tabl. w pojemniku\n05909990944019 ¦ OTC ¦ 59877\n30 tabl.",
  "substance": "Calcii dobesilas 250 mg",
  "common_name": "Calcii dobesilas monohydricus",
  "pl_product_id": "100108705",
  "pozwolenie_nr": "09440",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about calcium dobesilate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.